Jazz Pharmaceuticals plc Increase (Decrease) in Prepaid Expense and Other Assets
Jazz Pharmaceuticals plc (JAZZ) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$56.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-03
- Jazz Pharmaceuticals plc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$4.90M, a 122.79% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$51.90M.
- Jazz Pharmaceuticals plc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$27.49M, a 220.35% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $18.36M, a 46.25% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$29.03M, a 231.15% decline from fiscal 2024.
- Jazz Pharmaceuticals plc increase (decrease) in prepaid expense and other assets for fiscal 2024 was $22.14M, a 82.59% decline from fiscal 2023.
- Jazz Pharmaceuticals plc increase (decrease) in prepaid expense and other assets for fiscal 2023 was $127.11M.
- Jazz Pharmaceuticals plc increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$35.79M, a 142.95% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$56.80M 10-Q · filed 2026-08-03 | -$84.29M derived: sum of 3 quarters · filed 2026-08-03 | -$65.93M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2026-03-31 | -$51.90M 10-Q · filed 2026-05-05 | -$79.39M derived: sum of 2 quarters · filed 2026-05-05 | -$61.03M derived: sum of 3 quarters · filed 2026-05-05 | -$39.53M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-12-31 | -$27.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$9.13M derived: sum of 2 quarters · filed 2026-02-24 | $12.37M derived: sum of 3 quarters · filed 2026-08-03 | -$29.03M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $18.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $39.86M derived: sum of 2 quarters · filed 2026-08-03 | -$1.54M 10-Q · filed 2025-11-05 | $21.30M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-06-30 | $21.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$19.90M 10-Q · filed 2026-08-03 | -$8.21M 10-Q · filed 2025-08-06 | $2.94M derived: sum of 3 quarters · filed 2026-08-03 | $37.11M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | -$41.40M 10-Q · filed 2026-05-05 | -$36.28M 10-Q · filed 2025-05-07 | -$18.56M derived: sum of 2 quarters · filed 2026-05-05 | $15.61M derived: sum of 3 quarters · filed 2026-05-05 | $35.68M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $22.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $57.01M derived: sum of 2 quarters · filed 2026-02-24 | $77.08M derived: sum of 3 quarters · filed 2026-02-24 | $22.14M 10-K · filed 2026-02-24 | -$10.57M 10-K · filed 2025-02-26 | ||
| 2024-09-30 | $34.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $54.24M derived: sum of 2 quarters · filed 2025-11-05 | -$708.00K 10-Q · filed 2025-11-05 | $89.08M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | $20.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$34.87M 10-Q · filed 2025-08-06 | $54.92M derived: sum of 3 quarters · filed 2026-02-24 | $88.85M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | -$54.95M 10-Q · filed 2025-05-07 | $34.84M derived: sum of 2 quarters · filed 2026-02-24 | $68.78M derived: sum of 3 quarters · filed 2026-02-24 | $114.20M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | $89.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $123.72M derived: sum of 2 quarters · filed 2026-02-24 | $169.15M derived: sum of 3 quarters · filed 2026-02-24 | $127.11M 10-K · filed 2026-02-24 | $126.18M 10-K · filed 2024-02-28 | ||
| 2023-09-30 | $33.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $79.36M derived: sum of 2 quarters · filed 2024-11-07 | $37.33M 10-Q · filed 2024-11-07 | $25.34M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | $45.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $3.39M 10-Q · filed 2024-08-01 | -$8.60M derived: sum of 3 quarters · filed 2025-02-26 | -$9.74M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | -$42.03M 10-Q · filed 2024-05-02 | -$54.02M derived: sum of 2 quarters · filed 2025-02-26 | -$55.17M derived: sum of 3 quarters · filed 2025-02-26 | -$54.65M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | -$11.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$13.13M derived: sum of 2 quarters · filed 2025-02-26 | -$12.62M derived: sum of 3 quarters · filed 2025-02-26 | -$35.79M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$631.00K derived: sum of 2 quarters · filed 2023-11-08 | -$23.80M 10-Q · filed 2023-11-08 | $24.80M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | $516.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$22.65M 10-Q · filed 2023-08-09 | $25.94M derived: sum of 3 quarters · filed 2024-02-28 | $39.31M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | -$23.17M 10-Q · filed 2023-05-10 | $25.43M derived: sum of 2 quarters · filed 2024-02-28 | $38.80M derived: sum of 3 quarters · filed 2024-02-28 | $57.25M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $48.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $61.97M derived: sum of 2 quarters · filed 2024-02-28 | $80.42M derived: sum of 3 quarters · filed 2024-02-28 | $83.32M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $13.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $31.82M derived: sum of 2 quarters · filed 2022-11-09 | $34.72M 10-Q · filed 2022-11-09 | $67.86M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $18.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $21.35M 10-Q · filed 2022-08-03 | $54.49M derived: sum of 3 quarters · filed 2023-03-01 | $74.54M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | $2.90M 10-Q · filed 2022-05-04 | $36.04M derived: sum of 2 quarters · filed 2023-03-01 | $56.09M derived: sum of 3 quarters · filed 2023-03-01 | $83.10M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $33.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $53.19M derived: sum of 2 quarters · filed 2023-03-01 | $80.20M derived: sum of 3 quarters · filed 2023-03-01 | $98.04M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $20.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $47.06M derived: sum of 2 quarters · filed 2021-11-09 | $64.90M 10-Q · filed 2021-11-09 | $67.69M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $27.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $44.85M 10-Q · filed 2021-08-03 | $47.65M derived: sum of 3 quarters · filed 2022-03-01 | $54.57M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $17.84M 10-Q · filed 2021-05-04 | $20.64M derived: sum of 2 quarters · filed 2022-03-01 | $27.56M derived: sum of 3 quarters · filed 2022-03-01 | $42.51M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $9.72M derived: sum of 2 quarters · filed 2022-03-01 | $24.66M derived: sum of 3 quarters · filed 2022-03-01 | $25.65M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $6.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $21.87M derived: sum of 2 quarters · filed 2020-11-02 | $22.86M 10-Q · filed 2020-11-02 | $23.15M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-06-30 | $14.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $15.93M 10-Q · filed 2020-08-04 | $16.22M derived: sum of 3 quarters · filed 2021-02-23 | $3.96M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-03-31 | $988.00K 10-Q · filed 2020-05-05 | $1.28M derived: sum of 2 quarters · filed 2021-02-23 | -$10.98M derived: sum of 3 quarters · filed 2021-02-23 | -$9.24M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2018-12-31 | $292.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$11.96M derived: sum of 2 quarters · filed 2021-02-23 | -$10.23M derived: sum of 3 quarters · filed 2021-02-23 | -$6.70M 10-K · filed 2021-02-23 | |||
| 2018-09-30 | -$12.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$10.52M derived: sum of 2 quarters · filed 2019-11-05 | -$6.99M 10-Q · filed 2019-11-05 | $9.29M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $5.27M 10-Q · filed 2019-08-06 | $21.55M derived: sum of 3 quarters · filed 2020-02-25 | $31.27M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | $3.53M 10-Q · filed 2019-05-07 | $19.82M derived: sum of 2 quarters · filed 2020-02-25 | $29.54M derived: sum of 3 quarters · filed 2020-02-25 | $19.77M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $16.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $26.00M derived: sum of 2 quarters · filed 2020-02-25 | $16.24M derived: sum of 3 quarters · filed 2020-02-25 | $26.87M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $9.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$47.00K derived: sum of 2 quarters · filed 2018-11-06 | $10.59M 10-Q · filed 2018-11-06 | $17.78M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | -$9.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $870.00K 10-Q · filed 2018-08-07 | $8.06M derived: sum of 3 quarters · filed 2019-02-26 | $6.24M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $10.64M 10-Q · filed 2018-05-08 | $17.82M derived: sum of 2 quarters · filed 2019-02-26 | $16.00M derived: sum of 3 quarters · filed 2019-02-26 | $25.11M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $7.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $5.37M derived: sum of 2 quarters · filed 2019-02-26 | $14.47M derived: sum of 3 quarters · filed 2019-02-26 | $15.70M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | -$1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $7.28M derived: sum of 2 quarters · filed 2017-11-07 | $8.51M 10-Q · filed 2017-11-07 | -$506.00K derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $9.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $10.34M 10-Q · filed 2017-08-08 | $1.32M derived: sum of 3 quarters · filed 2018-02-27 | -$7.06M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $1.23M 10-Q · filed 2017-05-09 | -$7.79M derived: sum of 2 quarters · filed 2018-02-27 | -$16.16M derived: sum of 3 quarters · filed 2018-02-27 | -$18.16M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | -$9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$17.40M derived: sum of 2 quarters · filed 2018-02-27 | -$19.39M derived: sum of 3 quarters · filed 2018-02-27 | -$3.72M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | -$8.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$10.37M derived: sum of 2 quarters · filed 2016-11-08 | $5.30M 10-Q · filed 2016-11-08 | -$2.38M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | -$1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $13.68M 10-Q · filed 2016-08-09 | $6.00M derived: sum of 3 quarters · filed 2017-02-28 | $2.68M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | $15.67M 10-Q · filed 2016-05-10 | $8.00M derived: sum of 2 quarters · filed 2017-02-28 | $4.67M derived: sum of 3 quarters · filed 2017-02-28 | $8.09M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | -$7.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$11.00M derived: sum of 2 quarters · filed 2017-02-28 | -$7.58M derived: sum of 3 quarters · filed 2017-02-28 | -$11.94M 10-K · filed 2017-02-28 | |||
| 2014-09-30 | -$3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $95.00K derived: sum of 2 quarters · filed 2015-11-09 | -$4.26M 10-Q · filed 2015-11-09 | -$1.69M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-06-30 | $3.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$936.00K 10-Q · filed 2015-08-05 | $1.64M derived: sum of 3 quarters · filed 2016-02-23 | -$1.74M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-03-31 | -$4.36M 10-Q · filed 2015-05-07 | -$1.79M derived: sum of 2 quarters · filed 2016-02-23 | -$5.16M derived: sum of 3 quarters · filed 2016-02-23 | $3.24M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2013-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | -$801.00K derived: sum of 2 quarters · filed 2016-02-23 | $7.60M derived: sum of 3 quarters · filed 2016-02-23 | $13.87M 10-K · filed 2016-02-23 | |||
| 2013-09-30 | -$3.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $5.03M derived: sum of 2 quarters · filed 2014-11-04 | $11.30M 10-Q · filed 2014-11-04 | $20.55M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-06-30 | $8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $14.67M 10-Q · filed 2014-08-05 | $23.92M derived: sum of 3 quarters · filed 2015-02-24 | $22.37M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-03-31 | $6.27M 10-Q · filed 2014-05-08 | $15.52M derived: sum of 2 quarters · filed 2015-02-24 | $13.97M derived: sum of 3 quarters · filed 2015-02-24 | $17.15M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2012-12-31 | $9.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $7.70M derived: sum of 2 quarters · filed 2015-02-24 | $10.87M derived: sum of 3 quarters · filed 2015-02-24 | $13.09M 10-K · filed 2015-02-24 | |||
| 2012-09-30 | -$1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $1.63M derived: sum of 2 quarters · filed 2013-11-05 | $3.84M 10-Q · filed 2013-11-05 | $3.73M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-06-30 | $3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $5.39M 10-Q · filed 2013-08-06 | $5.27M derived: sum of 3 quarters · filed 2014-02-25 | $4.50M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-03-31 | $2.22M 10-Q · filed 2013-05-07 | $2.10M derived: sum of 2 quarters · filed 2014-02-25 | $1.33M derived: sum of 3 quarters · filed 2014-02-25 | $2.31M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2011-12-31 | -$117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$886.00K derived: sum of 2 quarters · filed 2014-02-25 | $92.00K derived: sum of 3 quarters · filed 2014-02-25 | $934.00K 10-K · filed 2014-02-25 | |||
| 2011-09-30 | -$769.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $209.00K derived: sum of 2 quarters · filed 2012-11-09 | $1.05M 10-Q · filed 2012-11-09 | $234.00K derived: sum of 4 quarters · filed 2013-02-26 | |||
| 2011-06-30 | $978.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $1.82M 10-Q · filed 2012-08-07 | $1.00M derived: sum of 3 quarters · filed 2013-02-26 | $882.00K derived: sum of 4 quarters · filed 2013-02-26 | |||
| 2011-03-31 | $842.00K 10-Q · filed 2012-05-08 | $25.00K derived: sum of 2 quarters · filed 2013-02-26 | -$96.00K derived: sum of 3 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | -$817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$938.00K derived: sum of 2 quarters · filed 2013-02-26 | -$426.00K 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | -$121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $391.00K 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $512.00K 10-Q · filed 2011-08-03 | ||||||
| 2009-12-31 | -$2.61M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |